Asthma Inhaler Monitoring Expands to Insurers
Patients using controller inhalers may soon have remote tracking covered through insurer and health system programs.
Updated on Nov. 1, 2026 in Asthma

Live Poll
Do you think healthcare access for chronic conditions is getting better or worse?
Adherium reported that recurring subscription revenue from its remote patient monitoring business rose 12.5% to $539,000 in the September quarter, its fifth consecutive quarterly record. The company's Hailie asthma monitoring device, which tracks inhaler use, is being extended into value-based care contracts with insurers and health systems in the United States.
Why it matters
Remote monitoring tools that track how patients use asthma inhalers are increasingly tied to how care is paid for, which affects whether patients get follow-up support between clinic visits. The shift toward value-based contracts reflects a broader push to reward outcomes rather than the volume of equipment or visits.
These figures are company-reported financial and device activation numbers rather than independent clinical outcomes data. Adherium states that more than 90% of Allergy Partners clinic locations now participate, but the filing does not report patient health outcomes.
The players
Adherium
A digital health company whose Hailie device monitors inhaler use to support asthma care.
Lurie Children's Hospital
A Chicago pediatric hospital that Adherium plans to partner with on a 20-person feasibility study.
The details
The Hailie device attaches to an inhaler and records when and how often it is used, allowing care teams to see whether patients are taking their controller medications as prescribed. Adherium recognizes billable revenue when patients activate devices rather than when equipment ships, so revenue tracks actual patient enrollment. Early engagement was improved through dedicated clinical support in the first seven days after activation, followed by more targeted outreach.
Timeline
July: John Perry became interim chief executive officer.
September quarter: Recurring subscription revenue rose 12.5% to $539,000, a fifth consecutive record.
October: Brad Wilson joined as chief financial officer.
November: A final Medicare rule was expected and could differ from the July proposal.
Health Landscape
Remote monitoring of asthma controller use is moving from a device-sales model toward payment arrangements linked to patient engagement and outcomes. Whether these tools change asthma control at the population level depends on evidence from studies like the planned feasibility work, which has yet to report.
If you have asthma, it is worth asking your clinician whether remote inhaler monitoring might help you track controller use between visits. Because these programs are expanding into insurer contracts, coverage may vary, so check with your plan and your doctor before assuming it is available to you.
The takeaway
Tracking whether controller inhalers are used as prescribed can help care teams spot gaps early. Ask your doctor whether connected inhaler monitoring is an option, and keep track of how your asthma symptoms change between appointments.
What happens next
A final Medicare rule on remote monitoring payment was expected in November, and it could differ from the July proposal, which would affect how these services are reimbursed.
Further reading
For more on how asthma care is managed day to day, explore our Asthma coverage.
Source note: This article includes information reported by Small Caps.
Live Poll
Do you think healthcare access for chronic conditions is getting better or worse?





